Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?
A panel of precision medicine experts from Children’s hospitals take part in a conversation that highlights the work being done to improve the way rare diseases and pediatric cancer is diagnosed and treated.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Although it has focused on diabetes management, Founder and CEO Laurence Girard says that the company is growing its telemedicine services to include virtual primary care support for other chronic conditions such as hypertension, mental health and smoking cessation that pair community and clinical components.
With artificial intelligence and machine learning algorithms are becoming more in vogue in different aspects of healthcare, our panel discusses how can we ensure that AI is leveraged properly so that it advances the goals of health equity.
Mental health is an area that needs to be better integrated into primary care. Learn the best strategies for doing so and the challenges that need to be overcome in this important discussion.
Listen in as our panel discusses how to achieve the right balance to combine the importance of technology while providing human touch to healthcare.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Starting in April, long-awaited interoperability regulations go into effect where patients will have unprecedented access to their data. Learn from patient advocates, health systems and others how the changes affect them.
Our panel discusses how pharma companies can ensure patients have access to life-saving drugs or those that significantly improve the quality of life as well as closing the gap with diversity in clinical trials.
Our expert panel weighs in on health systems addressing behavioral issues and supporting the mental health of doctors, nurses and others.
Learn from our expert panel as they discuss the challenges and opportunities of value-based contracting.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Learn from payers focused on health tech, medical device investors and others on what investment trends to watch for this year.
Covid-19 has renewed interest in diagnostics and a way to deliver care at home. Learn from companies and experts as they address the future of these two developments.
Learn how health systems and health plans are addressing care gaps with minorities and what strategies are being utilized to close those gaps.
As part of MedCity's 2021 INVEST conference, Cesar de la Fuente, presidential assistant professor at the University of Pennsylvania, explains the value of the rapid low-cost diagnostic test he has developed to detect SARS-CoV-2 and how the platform technology can be deployed to detect other diseases cost-effectively.
Skip Kelly, a managing director at J.P. Morgan, provides a broad overview of how the healthcare investment landscape is shaping up in the midst of a historic pandemic, as part of MedCity's 2021 INVEST conference.